Skip to main content

Applied Therapeutics, Inc.

APLTDelisted Feb 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001697532

Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.

Q4 2025 vs. Q3 2025

How the institutions holding Applied Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of APLT: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders70252−16
Shares94.8M53.1K58.9M−35.8M (−37.8%)
Value$57.2M$32.3K$5.93M−$51.2M (−89.6%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Applied Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to APLT in Q4 2025
InstitutionSharesValue% of portfolio
Deltec Asset Management LLC3,847,449$384.7K0.06%
Renaissance Technologies LLC2,706,156$270.6K0.00%
Jane Street Group, LLC2,087,404$208.7K0.00%
Graham Capital Management, L.P.572,759$57.3K0.00%
Lynx1 Capital Management LP410,500$41.0K0.01%
Equitec Proprietary Markets, LLC300,600$30.1K0.14%
GTS Securities LLC200,009$20.0K0.00%
Point72 Asset Management, L.P.17,020$1.70K0.00%
Optiver Holding B.V.427$430.00%

Sold out (25)

Institutions that held Applied Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (2)

Institutions that held Applied Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APLT in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Point72 Asia (Singapore) Pte. Ltd.32,702$19.8K
Wolverine Trading, LLC20,405$12.5K